Cargando…
The Suppressive Effect of Leucine-Rich Glioma Inactivated 3 (LGI3) Peptide on Impaired Skin Barrier Function in a Murine Model Atopic Dermatitis
This study aimed to restore the skin barrier function from atopic dermatitis (AD) via treatment with leucine-rich glioma inactivated 3 (LGI3) peptide. Male NC/Nga mice (7 weeks, 20 g) were randomly allocated into three groups (control, AD, and LGI3 group). After induction of AD skin lesions with Der...
Autores principales: | Kim, Ui Seok, Park, Jin Woo, Park, Eon Sub, Bang, Joon Seok, Jung, Tae Woo, Kim, Dong-Seok, Abd El-Aty, A. M., Lee, Jong Hyuk, Jeong, Ji Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463480/ https://www.ncbi.nlm.nih.gov/pubmed/32785038 http://dx.doi.org/10.3390/pharmaceutics12080750 |
Ejemplares similares
-
Motor Phenomena Associated With Leucine-Rich Glioma-Inactivated (LGI1) Emi-Encephalitis
por: Giorelli, Maurizio, et al.
Publicado: (2023) -
Leucine-rich glioma inactivated 3: integrative analyses support its prognostic role in glioma
por: Kwon, Nyoun Soo, et al.
Publicado: (2017) -
Leucine rich repeat LGI family member 3: Integrative analyses reveal its prognostic association with non-small cell lung cancer
por: Kim, Dong-Seok, et al.
Publicado: (2019) -
Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies
por: Smyth, Duncan, et al.
Publicado: (2021) -
Imbalance of glutamatergic and GABAergic neurotransmission in audiogenic seizure-susceptible Leucine-rich glioma-inactivated 1 (Lgi1)-mutant rats
por: Kinboshi, Masato, et al.
Publicado: (2023)